CAS 1922098-69-8

Formula: C23H19ClF2N2O3

InChI: InChI=1S/C23H19ClF2N2O3/c24-18-6-8-19(9-7-18)27-21(29)17-12-23(25,26)14-28(13-17)22(30)16-4-1-3-15(11-16)20-5-2-10-31-20/h1-11,17H,12-14H2,(H,27,29)

InChI key: PMTPYUTZAJWGPE-UHFFFAOYSA-N

SMILES: C1C(CN(CC1(F)F)C(=O)C2=CC=CC(=C2)C3=CC=CO3)C(=O)NC4=CC=C(C=C4)Cl

CCG-222740

CAS: 1922098-69-8

CCG-222740

Formula: C₂₃H₁₉ClF₂N₂O₃

Purezza: 98.5%

Peso molecolare: 444.86

Ref: 54-BUP09831

N-(4-Chlorophenyl)-5,5-difluoro-1-(3-(furan-2-yl)benzoyl)piperidine-3-carboxamide

CAS: 1922098-69-8

Formula: C₂₃H₁₉ClF₂N₂O₃

Purezza: 98%

Colore e forma: Solid

Peso molecolare: 444.8584

Ref: IN-DA01KJXC

CCG-222740

CAS: 1922098-69-8

CCG-222740 is an inhibitor of Rho/MRTF pathway

Formula: C₂₃H₁₉ClF₂N₂O₃

Purezza: 98.76%

Colore e forma: Solid

Peso molecolare: 444.858

Ref: TM-T7764

N-(4-Chlorophenyl)-5,5-difluoro-1-(3-(furan-2-yl)benzoyl)piperidine-3-carboxamide

CAS: 1922098-69-8

Formula: C₂₃H₁₉ClF₂N₂O₃

Purezza: 98%

Peso molecolare: 444.86

Ref: 10-F547062

CCG-222740

CAS: 1922098-69-8

CCG-222740 is a small molecule inhibitor, which is derived from synthetic chemistry advancements aimed at developing targeted cancer therapies. It operates by modulating specific signaling pathways that are known to contribute to tumor growth and survival. Specifically, CCG-222740 targets the Rho GTPase family, which is involved in regulating cytoskeletal dynamics and cell proliferation.

Formula: C₂₃H₁₉ClF₂N₂O₃

Purezza: Min. 95%

Peso molecolare: 444.86 g/mol

Ref: 3D-XBD09869